Cyrus Biotechnology: Funding, Investors & Team (Oct 2026)
Cyrus Biotechnology builds software tools to accelerate basic research in biotech, pharma, and industrial biotechnology. Cyrus Bench delivers an enterprise version of the Rosetta molecular modeling and design toolkit, with the associated array of bio-molecular computation tools. It was founded in 2014 and headquartered in Seattle, Washington.
Cyrus Biotechnology has raised $27.1M across 2 funding rounds on record, the most recent a Series B of $18.0M announced in Dec 2021.
That round is above the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Cyrus Biotechnology Company Profile and Key Stats
Latest funding round on record: Dec 2021.
Cyrus Biotechnology Funding Rounds
Cyrus Biotechnology raised $9.1M in an undisclosed round announced in Jul 2021.
5 months later, a Series B of $18.0M was announced in Dec 2021.
Cyrus Biotechnology Founders and Leadership Team
No contact details are on record for this team yet.
Cyrus Biotechnology Funding Compared to Other Biotechnology Startups
Cyrus Biotechnology's latest round of $18.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Cyrus Biotechnology in Biotechnology and Seattle
Companies Similar to Cyrus Biotechnology
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…
Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…
Datavant is a developer of a healthcare data platform dedicated to assisting in protecting, matching, and…
Cyrus Biotechnology Funding FAQs
What does Cyrus Biotechnology do?
Cyrus Biotechnology builds software tools to accelerate basic research in biotech, pharma, and industrial biotechnology. Cyrus Bench delivers an enterprise version of the Rosetta molecular modeling and design toolkit, with the associated array of bio-molecular computation tools. It was founded in 2014 and headquartered in Seattle, Washington.
How much funding has Cyrus Biotechnology raised?
Cyrus Biotechnology has raised $27.1M across 2 rounds on record. The most recent is a Series B of $18.0M announced in Dec 2021.
When did Cyrus Biotechnology last raise funding?
Cyrus Biotechnology's most recent funding round on record is a Series B of $18.0M, announced in Dec 2021.
Who is the CEO of Cyrus Biotechnology?
Lucas Nivon is listed as CEO at Cyrus Biotechnology.
Where is Cyrus Biotechnology headquartered?
Cyrus Biotechnology is based in Seattle, Washington, United States.
How many employees does Cyrus Biotechnology have?
Cyrus Biotechnology is in the 11-50 employee band.
How does Cyrus Biotechnology's funding compare to other Biotechnology startups?
Cyrus Biotechnology's latest round of $18.0M is above the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Cyrus Biotechnology Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Cyrus Biotechnology is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.